Peripheral Neuropathy Trial, Recruiting (NCT05501262)

Peripheral Neuropathy Trial, Recruiting NCT05501262 Sponsor: Oregon Health and Science University Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT05501262 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are older than 18 years of age
People who are able to give informed consent and fill out questionnaires
People who have already tried at least four weeks of non-surgical treatments (such as shoe inserts, appropriate footwear, or metatarsal pads) without enough improvement
People who have had an X-ray and ultrasound confirming the presence and location of a Morton's neuroma, with no other conditions found that could explain their symptoms

Who may not be able to join:

People who are unable to attend follow-up appointments or complete the required follow-up steps
People for whom cryoablation (a freezing treatment) or lidocaine/steroid injections are medically unsuitable
People whose imaging has found another condition that could be causing their foot symptoms
People who are not willing to be randomly assigned to one of the treatment groups in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Claire Kaufman, Oregon Health and Science University

Phone: 503-494-7226

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05501262

Sponsor: Oregon Health and Science University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 503-494-7226

More information: https://clinicaltrials.gov/study/NCT05501262

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are older than 18 years of age
People who are able to give informed consent and fill out questionnaires
People who have already tried at least four weeks of non-surgical treatments (such as shoe inserts, appropriate footwear, or metatarsal pads) without enough improvement
People who have had an X-ray and ultrasound confirming the presence and location of a Morton's neuroma, with no other conditions found that could explain their symptoms

Who may not be able to join:

People who are unable to attend follow-up appointments or complete the required follow-up steps
People for whom cryoablation (a freezing treatment) or lidocaine/steroid injections are medically unsuitable
People whose imaging has found another condition that could be causing their foot symptoms
People who are not willing to be randomly assigned to one of the treatment groups in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Oregon Health and Science University

Registry

ClinicalTrials.gov

Start date

25 July 2022

Est. completion

30 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in quality of life; Réponse in pain; Changes to function; Changes pain and function due to neuroma; Incidence of Treatment - Emergent Adverse Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov